Kymera Therapeutics: Q2 Earnings Insights

 

Kymera Therapeutics KYMR reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Kymera Therapeutics missed estimated earnings by 8.33%, reporting an EPS of $-0.78 versus an estimate of $-0.72.

Revenue was down $7.00 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.05 which was followed by a 11.41% drop in the share price the next day.

 

To track all earnings releases for Kymera Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

KYMR Logo
KYMRKymera Therapeutics Inc
$29.49-2.25%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
21.34
Growth
Not Available
Quality
Not Available
Value
10.52
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Comments
Loading...